Quantum Biopharma (QNTM) EPS (Basic) (2019 - 2026)
Quantum Biopharma's (QNTM) quarterly EPS (Basic) came in at $3.06 in Q1 2026, up 186.69% year-on-year from $1.07 in Q1 2025, and up 20495234236.35% quarter-over-quarter from -$0.0 in Q4 2025.
Quantum Biopharma (QNTM) EPS (Basic) (2019 - 2026) Analysis & Trends
Quantum Biopharma has disclosed EPS (Basic) across 8 years of filings, most recently posting $3.06 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at $3.06, up 186.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.04 (up 456.25% YoY), and the FY2025 annual result was -$4.71, changed N/A from the prior year.
- EPS (Basic) came in at $3.06 for Q1 2026 at Quantum Biopharma, up from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $4.37 in Q3 2024 to a low of -$3.53 in Q1 2025.
- The 5-year median for EPS (Basic) is -$0.02 (2023), against an average of $0.54.
- Across the five-year window, EPS (Basic) tumbled 285.71% in 2023 and jumped 14666.67% in 2024, its largest moves.
- Quantum Biopharma's EPS (Basic) stood at -$0.19 in 2022, then soared by 72.54% to -$0.05 in 2023, then surged by 73.31% to -$0.01 in 2024, then jumped by 100.0% to -$0.0 in 2025, then surged by 20495234236.35% to $3.06 in 2026.
- The last three EPS (Basic) figures came in at $3.06 (Q1 2026), -$0.0 (Q4 2025), and -$1.25 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 6.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.06 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -1.25 |
| Jun 30, 2025 | 3.23 |
| Mar 31, 2025 | -3.53 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 4.37 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 3.43 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.26 |
| Sep 30, 2022 | -0.19 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | 0.14 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2021 | -0.35 |
| Mar 31, 2021 | 0.35 |
| Sep 30, 2020 | -0.98 |